21+ only · Ships worldwide
Sequence, molecular weight, verified purity and available formats for all 41 compounds we supply.
41 of 41
| Compound | Code | Area | Sequence | Mol. weight | Purity | Formats |
|---|---|---|---|---|---|---|
| 51MQ | 51MQ-100 | Longevity & Cellular | C10H12N2O (small molecule) | 173.21 Da | 98.7% | Vial · Pen |
| ALPHA | TA1-5 | Recovery & Repair | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH | 3108.3 Da | 99.3% | Pen · Vial |
| AOD | AOD-5 | Metabolic & Weight | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe | 1815.08 Da | 99% | Pen · Vial |
| BPC-157 | BPC-5 | Recovery & Repair | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | 1419.53 Da | 99.2% | Pen · Vial |
| CAR | AICAR-50 | Metabolic & Weight | 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | 338.21 Da | 99% | Pen · Vial |
| CJC | CJC-5 | Growth Hormone | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 | 3367.97 Da | 98.9% | Pen · Vial |
| EPILON | EPI-20 | Longevity & Cellular | Ala-Glu-Asp-Gly | 390.35 Da | 99.4% | Pen · Vial |
| FRAG | FRAG-5 | Growth Hormone | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe | 1817.12 Da | 99.1% | Pen · Vial |
| GHK | GHK-100 | Recovery & Repair | Gly-His-Lys:Cu(II) | 403.93 Da | 98.5% | Pen · Vial |
| GHKCU-Nasal | GHK-100 | Recovery & Repair | Gly-His-Lys:Cu(II) | 403.93 Da | 98.5% | Nasal |
| GLOW | GLOW-40 | Recovery & Repair | BPC-157 + TB-500 + GHK-Cu | Combo | 99% | Pen · Vial |
| GLP-3 Reta | RETA-30 | Metabolic & Weight | Triple GIP/GLP-1/GCGR agonist | 4604.2 Da | 99.3% | Vial · Pen |
| GLP-4 Reta | RETA2-35 | Metabolic & Weight | Retatrutide + Cagrilintide | Combo | 99.2% | Pen · Vial |
| GLUTA | GSH-2000 | Longevity & Cellular | γ-L-Glutamyl-L-cysteinyl-glycine | 307.32 Da | 99.5% | Vial · Pen |
| IPAM | IPA-10 | Growth Hormone | Aib-His-D-2Nal-D-Phe-Lys-NH2 | 711.85 Da | 99.5% | Pen · Vial |
| JARO | TIRZ-15 | Metabolic & Weight | Modified dual GIP/GLP-1 agonist | 4813.45 Da | 99.4% | Pen · Vial |
| KLOW | KLOW-45 | Recovery & Repair | TB-500 + BPC-157 + KPV + GHK-Cu | Combo | 99% | Pen · Vial |
| KPV | KPV-10 | Recovery & Repair | Lys-Pro-Val | 342.43 Da | 99.1% | Pen · Vial |
| MOTS-C | MOTS-10 | Longevity & Cellular | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg | 2174.67 Da | 98.4% | Vial · Pen |
| MT2 | MT2-10 | Recovery & Repair | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 | 1024.18 Da | 99% | Pen · Vial |
| NAD+ | NAD-500 | Longevity & Cellular | C21H27N7O14P2 | 663.43 Da | 99% | Pen · Vial |
| PAM1295 | PAM-15 | Growth Hormone | CJC-1295 + Ipamorelin | Combo | 99.2% | Pen · Vial |
| PEPTIN | KISS-5 | Recovery & Repair | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | 1302.49 Da | 98.8% | Pen · Vial |
| PT141 | PT-10 | Recovery & Repair | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH | 1025.18 Da | 99% | Pen · Vial |
| PT141-NASAL | PT-10 | Longevity & Cellular | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH | 1025.18 Da | 99% | Nasal |
| RETA 60 | RETA-60 | Metabolic & Weight | Triple GIP/GLP-1/GCGR agonist | 4604.2 Da | 99.3% | Pen · Vial |
| RP2 | RP2-5 | Growth Hormone | D-Ala-D-2Nal-Ala-Trp-D-Phe-Lys-NH2 | 817.97 Da | 99% | Pen · Vial |
| RP6 | RP6-5 | Growth Hormone | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | 873.01 Da | 98.8% | Pen · Vial |
| SELANK | SEL-10 | Cognitive & Neuro | Thr-Lys-Pro-Arg-Pro-Gly-Pro | 751.90 Da | 98.8% | Pen · Vial |
| SELANK-NASAL | SELANK | Cognitive & Neuro | Thr-Lys-Pro-Arg-Pro-Gly-Pro | 751.90 Da | 98.8% | Nasal |
| SEMAX | SMX-10 | Cognitive & Neuro | Met-Glu-His-Phe-Pro-Gly-Pro | 813.93 Da | 99.3% | Pen · Vial |
| SEMAX-NASAL | SEMAX | Cognitive & Neuro | Met-Glu-His-Phe-Pro-Gly-Pro | 813.93 Da | 99.3% | Nasal |
| SERM | SER-5 | Growth Hormone | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | 3357.93 Da | 99.1% | Pen · Vial |
| SLUP332 | SLU-10 | Metabolic & Weight | Small molecule ERR agonist | 457.52 Da | 98.5% | Pen · Vial |
| SS31 | SS31-10 | Longevity & Cellular | D-Arg-Dmt-Lys-Phe-NH2 | 640.77 Da | 99.1% | Pen · Vial |
| TB-500 | TB-5 | Recovery & Repair | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES | 4963.44 Da | 98.7% | Vial · Pen |
| TB157 | TB157-10 | Recovery & Repair | BPC-157 + TB-500 | Combo | 99% | Pen · Vial |
| TESA | TESA-15 | Growth Hormone | Modified GHRH(1-44)-NH2 | 5135.9 Da | 99.3% | Pen · Vial |
| TIDE | CAGR-10 | Metabolic & Weight | Acylated amylin analogue | 3990.6 Da | 99.1% | Pen · Vial |
| VIP | VIP-5 | Recovery & Repair | His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | 3326.83 Da | 98.6% | Pen · Vial |
| ZEMPIC | SEMA-2 | Metabolic & Weight | Modified GLP-1(7-37) analogue | 4113.58 Da | 99.5% | Pen |
Purity figures are from reversed-phase HPLC analysis on the supplied batch. Certificates are in the COA database. For research use only.